| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |